Information Technology · Printed Circuit Boards

CTS CTS CORP SEC Filings & Insider Trading Activity 2026

company
CIK 26058120 filings
Russell 2000

CTS at a glance

CTS CORP (CTS, SEC CIK 26058) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on October 27, 2026, an 8-K current report on October 27, 2026 and Form 4 insider filings as recently as November 9, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), CTS CORP (CTS) reported revenue of $541.3 million (up 5.0% from FY2024) and net income of $65.3 million. Diluted EPS was $2.19.
  • As of September 30, 2026, 30 institutional investment managers tracked by SignalX reported holding CTS CORP (CTS) shares worth $742.7 million in 13F-HR filings.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$541.3M
+5.0% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
30 funds
$742.7M · −1 vs prior quarter
Latest 8-K
Oct 27, 2026
Item 7.01

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Business Overview

  • Core business model information not detailed; filing focuses on equity compensation and governance
  • Equity compensation plans include 786,209 securities outstanding with $36.48 weighted-average exercise price
  • 1,017,684 shares available for future issuance under approved equity plans as of December 31, 2025
  • Deferred stock accounts hold 4,722 CTS common stock units for non-employee directors, plan amended in 2004
  • No new products, segments, or strategic shifts disclosed in business section this year

Risk Factors

  • Acquisition of SyQwest for $121.9M on July 29, 2024, funded by cash and borrowings under prior revolving credit facility
  • Exposure to cyclicality in transportation market; warranty reserves 0.3%-0.4% of net sales, impacting product quality liability estimates
  • Operating lease obligations $25.3M with $3.45M due within 12 months for land, buildings, equipment critical to operations
  • Goodwill impairment testing relies on market capitalization and discount rates; risk of impairment if market cap declines significantly
  • Long-term debt $57.5M principal under Revolving Credit Facility with $12.0M interest payments through maturity, interest rate swaps hedge $50M through Dec 2026

Management Discussion & Analysis

  • Revenue $541.3M, up 5.2% YoY ($26.6M increase) driven by aerospace, defense, medical markets, SyQwest acquisition adding $22.3M
  • Gross margin 38.4% vs 36.4%, operating margin 15.3% vs 13.8%, net earnings $65.3M up 17.7%, diluted EPS $2.19 vs $1.81
  • Best segment: diversified end markets up $43.0M or 16.3%; worst segment: transportation down $16.4M or 6.6%
  • Operating cash flow $102.1M; capital expenditures $15.7M; treasury stock repurchases $56.2M; dividends $4.8M; debt reduced by $34.8M
  • New $300M revolving credit facility secured, matures 2030, management expects adequate liquidity; risk includes market softness and EPA settlement charge

AI summary of the CTS 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to risk factors from the December 31, 2025 Form 10-K
  • Continued risks include competitive pressure, based on carried-forward disclosures
  • Continued risks include regulatory and legal compliance exposure, based on carried-forward disclosures
  • Continued risks include liquidity, debt, and market exposure, based on carried-forward disclosures

Management Discussion & Analysis

  • Q3 revenue $149.6M, up 4.6% YoY from $143.0M, diversified markets up 6.6%
  • Gross margin 42.2% vs 38.7%; operating margin 17.1% vs 14.7%
  • Medical and industrial growth strongest; aerospace and defense declined on contract-award timing
  • Cash $143.9M vs $82.3M at December 31; operating cash flow $94.3M through nine months
  • Millar acquisition for $50.0M, up to $20.0M contingent consideration; tariffs, market softness and geopolitical risks remain headwinds

AI summary of the CTS 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Oct 27, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q3 2026 revenue $149.6M, up from $143.0M, with adjusted EPS $0.77 versus $0.60
  • LTM revenue $570.9M and adjusted EBITDA margin 24.7%, supporting continued margin expansion

Item 7.01: Regulation FD Disclosure

  • CTS investor presentation may be used in meetings with investors, analysts, and other stakeholders during fiscal 2026
  • Exhibit 99.1 contains the substantive investor-facing information relevant to CTS’s outlook and messaging
Filed Oct 27, 2026Full analysis →

Item EX-99.2: Item EX-99.2

  • Q3 revenue $149.6M, up 5% YoY, with adjusted EPS $0.77 versus $0.60
  • Adjusted gross margin expanded 330 bps to 42.2%, while adjusted EBITDA margin reached 24.7%

Item EX-99.1: Item EX-99.1

  • Q3 sales $149.6M, up 5%, with diversified markets up 7% and now 60% of total sales
  • Adjusted diluted EPS $0.77, up from $0.60, while adjusted EBITDA margin reached 24.7%

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 results for the quarter ended September 30, 2026 announced by CTS Corporation
  • Full operating and financial details contained in Exhibit 99.1 press release

Item 7.01: Regulation FD Disclosure

  • CTS webcast scheduled for October 27, 2026, covering third-quarter results ended September 30, 2026
  • Investor presentation slides furnished as Exhibit 99.2, providing supplemental context for the earnings discussion
Filed Jul 28, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • FY2026 revenue guidance $565–$585M and adjusted diluted EPS $2.55–$2.70
  • LTM revenue $564.3M, up from $541.3M, with adjusted EBITDA margin 24.0%

Item 7.01: Regulation FD Disclosure

  • Investor presentation available as Exhibit 99.1 for meetings with investors and analysts during fiscal 2026
  • Presentation may be modified or presented in parts, signaling supplemental investor communications rather than a new transaction

AI summaries of CTS 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for CTS

Don't miss the next CTS filing

  • Alerts as it files. A push when CTS files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut CTS, by share count.
  • Ask anything. An AI agent that reads every CTS filing and answers with sources.

CTS alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Dodrill Amy M.ANov 5, 2026-
Zulueta Alfonso GANov 5, 2026-
MacKay Kimberly BanksANov 5, 2026-
JOHNSON WILLIAM SANov 5, 2026-
Costello DonnaANov 5, 2026-
Stone Randy LeeANov 5, 2026-
PROFUSEK ROBERTANov 5, 2026-
O'SULLIVAN KIERAN MGOct 30, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$515.8M$541.3M
Gross Profit$190.9M$189.2M$208.0M
Operating Income-$72.8M$82.6M
Net Income$60.5M$58.1M$65.3M
Gross Margin-36.7%38.4%
Op. Margin-14.1%15.3%
Net Margin-11.3%12.1%
Balance Sheet
Total Assets$741.2M$766.1M$764.3M
Equity-$530.9M$551.8M
ROE-10.9%11.8%
Per Share
EPS$1.92$1.89$2.19
Cash Flow
Operating CF-$99.3M$102.1M

Source: XBRL data in CTS CORP (CTS)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate CTS share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
CTS shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202630$742.7M
Q2 202631$821.1M
Q1 202631$584.0M
Q4 202529$528.9M
Q3 202530$508.4M
Q2 202527$535.4M
Q1 202525$324.4M
Q4 202422$370.8M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 225 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

CTS filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 9, 2026--
4Nov 9, 2026--
4Nov 9, 2026--
4Nov 9, 2026--
4Nov 9, 2026--
4Nov 9, 2026--
4Nov 9, 2026--
4Nov 3, 2026--
8-KOct 27, 2026Analysis-
8-KOct 27, 2026Analysis-
10-QOct 27, 2026Analysis
4Jul 30, 2026--
8-KJul 28, 2026Analysis-
8-KJul 28, 2026Analysis-
10-QJul 28, 2026Analysis
4Jul 7, 2026--
8-KJun 25, 2026Analysis-
8-KMay 19, 2026Analysis
4May 12, 2026-
8-KApr 29, 2026Analysis-
8-KApr 29, 2026Analysis-
SC 13GApr 29, 2026-
10-QApr 29, 2026Analysis
4Feb 26, 2026--
4Feb 26, 2026--

Related Information Technology companies

All Information Technology →

CTS SEC filings: frequently asked questions

Which institutions hold CTS stock?

As of September 30, 2026, the largest CTS CORP (CTS) holders among the 13F filers tracked by SignalX were BlackRock ($265.7 million), Vanguard Portfolio Management LLC ($75.7 million), Vanguard Capital Management LLC ($73.7 million), Dimensional Fund Advisors ($71.2 million), State Street Corp ($70.9 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was CTS's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), CTS CORP (CTS) reported revenue of $541.3 million (up 5.0% from FY2024) and net income of $65.3 million. Diluted EPS was $2.19. The figures come from the XBRL data in the 10-K.

What are the main risks in CTS's latest 10-K?

In the 10-K filed February 24, 2026, CTS CORP (CTS) flagged: Acquisition of SyQwest for $121.9M on July 29, 2024, funded by cash and borrowings under prior revolving credit facility. Exposure to cyclicality in transportation market; warranty reserves 0.3%-0.4% of net sales, impacting product quality liability estimates. (AI summary of the Risk Factors section.)

What did CTS report in its latest 8-K?

CTS CORP (CTS) filed an 8-K on October 27, 2026 reporting Item 7.01 (Regulation FD Disclosure). Q3 2026 revenue $149.6M, up from $143.0M, with adjusted EPS $0.77 versus $0.60.

What are the latest CTS SEC filings?

CTS CORP (CTS) filed its latest 10-K annual report on February 24, 2026, a 10-Q quarterly report on October 27, 2026, an 8-K current report on October 27, 2026 and a Form 4 insider filing on November 9, 2026.

What is CTS's SEC CIK number?

CTS CORP (CTS)'s SEC Central Index Key (CIK) is 26058. EDGAR lists every CTS filing under that number.

Ask anything about CTS

The research agent reads CTS's filings, financials, insider trades and 13F holders, then answers with sources.